MLA 0.00% 8.5¢ medical australia limited

Similar, with no mention of cost to consumer, time taken for...

  1. 798 Posts.
    lightbulb Created with Sketch. 10
    Similar, with no mention of cost to consumer, time taken for procedure etc (both of medivets advantages over other stem cell offerings) also is rather late rolling this out to market.
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.